Clinical Trial Update: Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Tenofovir Alafenamide to prevent mother-to-child transmission of Hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Mother-to-child Transmission of Hepatitis

Drugs mentioned

• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Chronic Hepatitis B, Mother-to-Child Transmission | Phase 4 | Status: UNKNOWN